Orca Biosystems, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersMenlo Park, CA
SAM.gov UEISH1UEHKLZLP3
Orca Bio is a biotechnology company that develops high-precision cell therapies for cancer and autoimmune diseases, specifically investigational allogeneic T-cell immunotherapies that use regulatory T cells. The company has received U.S. FDA approval for TREGZI™, a precision-engineered cell therapy for allogeneic transplant in adults with hematological malignancies.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Orca Biosystems, INC | Menlo Park | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


